Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6673904

Title:Stem cell growth factor-like polypeptides
Inventors:Nishikawa, Mitsuo; Gunma, Japan
Labat, Ivan; Mountain View, CA, USA
Drmanac, Radoje T.; Palo Alto, CA, USA
Tang, Y. Tom; San Jose, CA, USA
Chao, Cheng-Chi; Cupertino, CA, USA
Mize, Nancy; Mountain View, CA, USA
Childs, John; Sunnyvale, CA, USA
Summary:This invention describes novel isolated stem cell polynucleotides and growth factor-like polypeptides encoded by such polynucleotides, and mutants or variants thereof. The polynucleotides are described as comprising nucleic acid sequences isolated from cDNA libraries prepared from mouse bone marrow and human fetal liver spleen, ovary, adult brain, lung tumor, spinal cord, cervix, ovary, endothelial cells, umbilical cord, placental, lymphocyte, lung fibroblast, fetal brain, and testis. Further disclosed are vectors containing processes for producing novel human secreted stem cell growth factor-like polypeptides, and antibodies specific for such polypeptides. Therapeutic applications are included, such as in the treatment of leukemia, hemophilia, osteoporosis, osteoarthritis, graft-versus-host disease, cancers, Alzheimer's disease, and Huntington's disease.
Abstract:The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human and mouse secreted stem cell growth factor-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA libraries prepared from mouse bone marrow and human fetal liver spleen, ovary, adult brain, lung tumor, spinal cord, cervix, ovary, endothelial cells, umbilical cord, placental, lymphocyte, lung fibroblast, fetal brain, and testis. Other aspects of the invention include vectors containing processes for producing novel human secreted stem cell growth factor-like polypeptides, and antibodies specific for such polypeptides.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6673904
Application Number:US2001000912935
Date Filed:24/07/2001
Date Published:06/01/2004
Assignee:Kirin Beer Kabushiki Kaisha, Tokyo, Japan Hyseq, Inc., Sunnyvale, CA, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/22/2021